Global Tissue Ablation Market 2017-2021


#1027778

111pages

Technavio

$ 3500

In Stock

About Tissue Ablation

Tissue ablation is a minimally invasive (MI), image-guided treatment modality used to treat, modify, or destroy cells (that are cancerous). In this process, a specifically equipped needle (probe) is inserted near the site of the tissue under study, and is guided by computed tomography (CT). Once the probe is in place, electricity (RFA), radio waves (microwave ablation), or liquid nitrogen (cryoablation) is transmitted through the probe. These kill the cells and reduce the size of the tissue (tumor), thereby facilitating effective treatment with radiation therapy or chemotherapy. The tissue ablation technique has proven beneficial for individuals with myocardial tissue, corneal surface laser ablation, prostate tissue, and small tumors (3-5 cm), but is not recommended for individuals with large tumors and impaired organ function.

Technavios analysts forecast the global tissue ablation market to grow at a CAGR of 9.91% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global tissue ablation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various tissue devices to key end-users such as hospitals, ambulatory surgical centers (ASCs), and physicians' offices.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Tissue Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Boston Scientific
Johnson & Johnson
Medtronic
St. Jude Medical

Other prominent vendors
Abbott Laboratories
Accuray
Acoustic Medsystems
Advanced Cardiac Therapeutics
Alcon
Alpinion Medical System
American Medical Systems
AtriCure
Biosense Webster
BIOTRONIK
Bovie Medical
BSD Medical
C.R. Bard
C2 Therapeutics
CardioFocus
Chongqing Haifu Medical Technology
Conmed
CSA Medical
Cynosure
Cytyc
EDAP TMS
Elekta
Esaote
Galil Medical
Hologic
InSightec
Lumenis
Mermaid Medical
MicroPort Scientific
Microsulis Medical
Monteris Medical
Neuwave Medical
Olympus
Perseon
Philips Healthcare
Plasma Surgical
PLC Medical Systems
Profound Medical
Shenzhen Huikang Medical Apparatus
Smith & Nephew
Sonacare Medical
Spectranetics
Stryker
Terumo Medical
Theraclion
Total Vein Systems
Varian Medical
Vimecon
Vivant Medical
Market driver
Rise in incidence of chronic diseases and older adult population.
For a full, detailed list, view our report

Market challenge
Complications associated with energy and laser based ablation devices.
For a full, detailed list, view our report

Market trend
Rise in accessibility to advanced laser treatments.
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Table of Contents

PART 01: Executive summary

PART 02: Scope of the report


Market overview
Top-vendor offerings


PART 03: Market research methodology


Research methodology
Economic indicators


PART 04: Introduction


Key market highlights


PART 05: Market landscape


Market overview
Market size and forecast
Five forces analysis


PART 06: Cost analysis

PART 07: Market segmentation by product


Global capital equipment market
Global ablation catheters market
Global tissue ablation consumables market


PART 08: Market segmentation by technology

PART 09: Market segmentation by application

PART 10: Market segmentation by end-user


ASCs
Hospitals
Physicians' offices


PART 11: Geographical segmentation


Tissue ablation market in the Americas
Market size and forecast
Tissue ablation market in EMEA
Market size and forecast
Tissue ablation market in APAC
Market size and forecast


PART 12: Market drivers


Rise in incidence of chronic diseases and older adult population
Increase in MI procedures
Advances in technology
Growing use of medical lasers for oncology procedures
Increase in disposable income


PART 13: Impact of drivers

PART 14: Market challenges


Complications associated with energy and laser-based ablation devices
Stringent regulatory approval processes
High cost of surgeries
Inadequate skilled practitioners


PART 15: Impact of drivers and challenges

PART 16: Market trends


Use of robotic navigation technologies
Focus on emerging countries
Focus on R&D
Rise in accessibility to advanced laser treatments


PART 17: Vendor landscape


Competitive scenario


PART 18: Key vendor analysis


Boston Scientific
Johnson & Johnson
Medtronic
St. Jude Medical
Other prominent vendors


PART 19: Appendix


List of abbreviations


PART 20: Explore Technavio
List of Exhibits

Exhibit 01: Product offerings

Exhibit 02: Global tissue ablation market 2016-2021 ($ billions)

Exhibit 03: Snapshot of global tissue ablation market 2016

Exhibit 04: Five forces analysis

Exhibit 05: Cost of tissue ablation devices 2016

Exhibit 06: Global tissue ablation market by product

Exhibit 07: Global tissue ablation market by capital equipment 2016-2021 ($ billions)

Exhibit 08: Global ablation catheters market 2016-2021 ($ billions)

Exhibit 09: Global tissue ablation market by consumables 2016-2021 ($ billions)

Exhibit 10: Cancer types worldwide 2012

Exhibit 11: Global tissue ablation market by product 2016 and 2021

Exhibit 12: Global tissue ablation market analysis by product 2016

Exhibit 13: Market growth lifecycle for tissue ablation products 2016

Exhibit 14: Global tissue ablation market by technology

Exhibit 15: Types of lasers used in medicine

Exhibit 16: Global tissue ablation market by technique 2016

Exhibit 17: Global tissue ablation market by technology

Exhibit 18: Global tissue ablation market by application 2016

Exhibit 19: Global tissue ablation market by end-user 2016

Exhibit 20: Comparison of reimbursement in ASCs, hospital outpatient departments, and physicians' offices in the US

Exhibit 21: Global tissue ablation market by geography 2016-2021

Exhibit 22: Global tissue ablation market: Geographical presence

Exhibit 23: Global tissue ablation market by geography 2016

Exhibit 24: Global tissue ablation market by geography 2016: Lifecycle analysis

Exhibit 25: Market overview: Americas

Exhibit 26: Tissue ablation market in Americas 2016-2021 ($ billions)

Exhibit 27: Image-guided MI procedures 2014 (in millions)

Exhibit 28: Prostate cancer incidence in top five European countries 2014

Exhibit 29: Tissue ablation market in EMEA 2016-2021 ($ billions)

Exhibit 30: Market overview: EMEA

Exhibit 31: Market overview: APAC

Exhibit 32: Tissue ablation market in APAC 2016-2021 ($ billions)

Exhibit 33: Global tissue ablation market by geography 2016-2021 ($ billions)

Exhibit 34: Global tissue ablation market by geography 2016-2021

Exhibit 35: Impact of drivers

Exhibit 36: Cost of various tissue ablation procedures

Exhibit 37: Impact of drivers and challenges

Exhibit 38: Competitive structure analysis of global tissue ablation market 2016

Exhibit 39: Vendors market share analysis 2015

Exhibit 40: Global tissue ablation market: Competitive landscape analysis 2016

Exhibit 41: Strategic factors determining success for companies in global tissue ablation market

Exhibit 42: Key highlights of Boston Scientific

Exhibit 43: Boston Scientific: Strength assessment

Exhibit 44: Boston Scientific: Strategy assessment

Exhibit 45: Boston Scientific: Opportunity assessment

Exhibit 46: Key highlights of Johnson & Johnson

Exhibit 47: Johnson & Johnson: Strength assessment

Exhibit 48: Johnson & Johnson: Strategy assessment

Exhibit 49: Johnson & Johnson: Opportunity assessment

Exhibit 50: Key highlights of Medtronic

Exhibit 51: Medtronic: Strength assessment

Exhibit 52: Medtronic: Strategy assessment

Exhibit 53: Medtronic: Opportunity assessment

Exhibit 54: St. Jude Medical key highlights

Exhibit 55: St. Jude Medical strength assessment

Exhibit 56: St. Jude Medical: Strategy assessment

Exhibit 57: St. Jude Medical: Opportunity assessment